Nanox Imaging (NASDAQ: NNOX) presented updated clinical data for its investigational HealthAVC aortic valve calcification software at TCT on November 1, 2026. In 440 evaluable chest CT scans from adults aged 50 and older, sensitivity was 98.3% and specificity was 96.6%, measuring detection of positive cases and exclusion of negative cases, respectively.Of 172 manually confirmed positive scans, 145 lacked explicit mention of calcification in their original reports; HealthAVC detected 142 of those cases. This measures reporting, not radiologists’ diagnostic errors. However, 56 of 496 submitted scans were non-evaluable; counting manually positive rejected scans as missed reduced end-to-end sensitivity to 89.9%. Selected follow-up data do not establish clinical benefit or a need for intervention. Findings were also published in JACC: Advances. HealthAVC remains under development, without clinical clearance or commercial availability.

🔥-65% ￥781🔥

The Israeli medical imaging firm's cash reserves fell by more than half in nine months, raising survival questions for its AI-plus-hardware convergence

La israelí Nanox AI firmó un acuerdo de distribución para comercializar en Italia su solución ósea HealthOST.

アマゾンでナノックスワン(NANOXone) 洗濯洗剤が2割引。 ・NANOX one プロ パウダリーソープ 詰替メガジャンボ 1730g 1,551円⇒1,255円、14pt（1％）ポイント付与で実質1,241円（2 […]

Stock Titan provides an ultra-fast stock market news feed and multiple tools for traders and investors.

Nano-X Imaging (NASDAQ: NNOX) announced its subsidiary Nanox AI signed a distribution agreement with Technologic to commercialize HealthOST in Italy.Technologic is affiliated with Tecnologie Avanzate but is the contractual counterparty. Nanox expects the collaboration to support its Italian commercial expansion by drawing on Tecnologie Avanzate's medical technology experience and local market knowledge. HealthOST, Nanox.AI's Bone solution, is designed to analyze the spine using eligible routine CT scans and support assessment of musculoskeletal disease, including osteoporosis.

Nanox Imaging (NNOX) announced that its Nanox.ARC X medical imaging system was selected for TIME’s Best Inventions of 2026 list. This marks Nanox’s second appearance and its first inclusion on the main list, following a Special Mentions recognition for Nanox.AI in 2024.Nanox.ARC X is an FDA-cleared digital tomosynthesis system, which uses X-ray images from multiple angles to produce a 3D view. Nanox will showcase the system at the RSNA 2026 Annual Meeting in Chicago.

Lead an expedition to the meteorite impact site.

🔥-70% ￥677🔥

YouTube video by Garrett's Games

YouTube video by Garrett's Games

Beeple Radio zur SPIEL'26 präsentiert von Beeple Auf der Road to Essen, SPIEL'26, durfte Jürgen bei dlp Games zu Gast sein. Geplaudert wird über - Loyalty Rome (dlp Games) - Unterwood (dlp Games) - ...